Aurinia unveils Positive CHMP Opinion for LUPKYNIS in Europe

Aurinia Pharmaceuticals Inc.(Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending voclosporin (brand name, LUPKYNIS) for marketing authorization to treat adults with active […]

US FDA Permits Covid -19 Booster Dose From PFizer and BioNtech

Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the Pfizer-BioNTech COVID-19 Vaccine for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years […]